Glorikian.com: Niven Narain and How AI and Machine Learning are Changing Drug Discovery


September 27, 2018

Harry Glorikian interviews Niven R. Narain, PhD., Co-Founder, President and CEO of BERG to discuss BERG’s philosophy: to combine a systems biology architecture with patients’ demographic data and clinical outcome data, and then apply Bayesian artificial intelligence algorithms to drive better understanding of diseases.

For the full interview, click here.

 

 

Recent news